Cited by 118Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.

Alzheimer's Disease Mechanisms and Emerging Roads to Novel Therapeutics

Open access

Sala Frigerio, Carlo, De Strooper, Bart·2016·Annual Review of Neuroscience

DOI 10.1146/annurev-neuro-070815-014015

Open this paper in CoChat — free account Open PDF

Abstract

Ten years of remarkable progress in understanding the fundamental biochemistry of Alzheimer's disease have been followed by ten years of remarkable and increasing clinical insight into the natural progression of the disorder. The concept of a long, intermediary, prodromal phase between the first appearance of amyloid plaques and tangles and the manifestation of dementia is now well established. The major challenge for the next decade is to chart the many cellular processes that underlie this phase and link the biochemical alterations to the clinical manifestation of Alzheimer's disease. We discuss here how genetics, new cell culture systems, and improved animal models will fuel this work. We anticipate that the resulting novel insights will provide a basis for further drug development for this terrible disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1146/annurev-neuro-070815-014015

Cites

163 of 163 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1×
“A growing body of evidence, both from histopathology assessment of the brain (Braak & Braak 1991) and from in vitro (Frost et al. 2009) and in vivo (Clavaguera et al. 2009, de Calignon et al. 2012) work, suggests that tau can propagate its abnormal aggregation to functionally connected brain areas,…”
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
The Future of Genetic Studies of Complex Human Diseases
Risch, N., & Merikangas, K. (1996) · Science · doi:10.1126/science.273.5281.1516 · Cited by 5,355
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396

Show all 163 references

Research works printed but not linked: 2

Aisen PS, 2012, Arch. Med. Sci., 7, 102
Podlisny MB, 1991, Am. J. Pathol., 138, 1423

Sorted by citations

Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies.
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
“109,170 However, the side effects associated with targeting β - and γ -secretases arise because these enzymes have a wide range of substrates that are vital in other physiological processes.”
Background
Inflammasomes in neuroinflammatory and neurodegenerative diseases
Voet, S., Srinivasan, S., Lamkanfi, M., & van Loo, G. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201810248 · Cited by 761
Synaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic strategies
Chen, Y., Fu, A. K. Y., & Ip, N. Y. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.006 · Cited by 258
CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice
Mancuso, R., Fryatt, G., Cleal, M., Obst, J., Pipi, E., Monzón-Sandoval, J., Ribe, E., Winchester, L., Webber, C., Nevado, A., et al. (2019) · Brain · doi:10.1093/brain/awz241 · Cited by 235
PLGA nanoparticles modified with a BBB-penetrating peptide co-delivering Aβ generation inhibitor and curcumin attenuate memory deficits and neuropathology in Alzheimer's disease mice
Huang, N., Lü, S., Liu, X., Zhu, J., Wang, Y., & Liu, R. (2017) · Oncotarget · doi:10.18632/oncotarget.20944 · Cited by 176
Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead
Kumar, D., Ganeshpurkar, A., Kumar, D., Modi, G. P., Gupta, S., & Singh, S. K. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.02.035 · Cited by 170
Selective targeting of primary and secondary nucleation pathways in Aβ42 aggregation using a rational antibody scanning method
Aprile, F. A., Sormanni, P., Perni, M., Arosio, P., Linse, S. S., Knowles, T. P. J., Dobson, C. M., & Vendruscolo, M. (2017) · Science Advances · doi:10.1126/sciadv.1700488 · Cited by 144
Pharmacologically reversible zonation-dependent endothelial cell transcriptomic changes with neurodegenerative disease associations in the aged brain
Zhao, L., Li, Z., Vong, J. S. L., Chen, X., Lai, H. M., Yan, L. Y. C., Huang, J., Sy, S. K. H., Tian, X. Y., Huang, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18249-3 · Cited by 125
Human Neurospheroid Arrays for In Vitro Studies of Alzheimer’s Disease
Jorfi, M., D’Avanzo, C., Tanzi, R. E., Kim, D. Y., & Irimia, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-20436-8 · Cited by 112
A combined miRNA-piRNA signature to detect Alzheimer’s disease
Jain, G., Stuendl, A., Rao, P., Berulava, T., Pena Centeno, T., Kaurani, L., Burkhardt, S., Delalle, I., Kornhuber, J., Hüll, M., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0579-2 · Cited by 121
Three‐Dimensional Models of the Human Brain Development and Diseases
Jorfi, M., D’Avanzo, C., Kim, D. Y., & Irimia, D. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700723 · Cited by 106
Nrf2 Ablation Promotes Alzheimer’s Disease-Like Pathology in APP/PS1 Transgenic Mice: The Role of Neuroinflammation and Oxidative Stress
Ren, P., Chen, J., Li, B., Zhang, M., Yang, B., Guo, X., Chen, Z., Cheng, H., Wang, P., Wang, S.-B., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/3050971 · Cited by 101
Astrocyte–neuron interplay is critical for Alzheimer's disease pathogenesis and is rescued by TRPA1 channel blockade
Paumier, A., Boisseau, S., Jacquier‐Sarlin, M. R., Pernet‐Gallay, K., Buisson, A., & Albrieux, M. (2021) · Brain · doi:10.1093/brain/awab281 · Cited by 114
Understanding zebrafish aggressive behavior
Zabegalov, K. N., Kolesnikova, T. O., Khatsko, S. L., Volgin, A. D., Yakovlev, O. A., Amstislavskaya, T. G., Friend, A. J., Bao, W., Alekseeva, P. A., Lakstygal, A. M., et al. (2018) · Behavioural Processes · doi:10.1016/j.beproc.2018.11.010 · Cited by 99
Synaptogenic effect of APP -Swedish mutation in familial Alzheimer’s disease
Zhou, B., Lu, J. G., Siddu, A., Wernig, M., & Südhof, T. C. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abn9380 · Cited by 99
Modulation of Brain Hyperexcitability: Potential New Therapeutic Approaches in Alzheimer’s Disease
Toniolo, S., Sen, A., & Husain, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239318 · Cited by 97
When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer’s and Huntington’s Disease
D’Mello, S. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115911 · Cited by 80
Associations of Regional Brain Structural Differences With Aging, Modifiable Risk Factors for Dementia, and Cognitive Performance
Suzuki, H., Venkataraman, A. V., Bai, W., Guitton, F., Guo, Y., Dehghan, A., Matthews, P. M., & Initiative, A. D. N. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.17257 · Cited by 73
Insights into lncRNAs in Alzheimer’s disease mechanisms
Li, D., Zhang, J., Li, X., Chen, Y., Feng, Y., & Liu, Q. (2020) · RNA Biology · doi:10.1080/15476286.2020.1788848 · Cited by 68
Circadian dysfunction and Alzheimer's disease – An updated review
Ahmad, F., Sachdeva, P., Sarkar, J., & Izhaar, R. (2022) · Aging Medicine · doi:10.1002/agm2.12221 · Cited by 70
Developing Therapies for Neurodegenerative Disorders: Insights from Protein Aggregation and Cellular Stress Responses
Mallucci, G. R., Klenerman, D., & Rubinsztein, D. C. (2020) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-040320-120625 · Cited by 62
Mechanisms of Intranasal Deferoxamine in Neurodegenerative and Neurovascular Disease
Kosyakovsky, J., Fine, J. M., Frey, W. H., & Hanson, L. R. (2021) · Pharmaceuticals · doi:10.3390/ph14020095 · Cited by 67
Conserved S/T Residues of the Human Chaperone DNAJB6 Are Required for Effective Inhibition of Aβ42 Amyloid Fibril Formation
Månsson, C., van Cruchten, R. T. P., Weininger, U., Yang, X., Cukalevski, R., Arosio, P., Dobson, C. M., Knowles, T. P. J., Akke, M., Linse, S. S., et al. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00353 · Cited by 63
Sleep and circadian rhythm disruption and stress intersect in Alzheimer's disease
Phan, T., & Malkani, R. G. (2018) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.10.001 · Cited by 66
MEK1/2 inhibition rescues neurodegeneration by TFEB-mediated activation of autophagic lysosomal function in a model of Alzheimer’s Disease
Chun, Y. S., Kim, M., Lee, S., Kim, M. J., Hong, T.-J., Jeon, J. K., Ganbat, D., Kim, H. T., Kim, S. S., Kam, T., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01713-5 · Cited by 56
Multi-Target Anti-Alzheimer Activities of Four Prenylated Compounds from Psoralea Fructus
Xu, Q., Hu, Y., Li, G., Xu, W., Zhang, Y., & Yang, X. (2018) · Molecules · doi:10.3390/molecules23030614 · Cited by 58
Cerebrospinal fluid proteomics and biological heterogeneity in Alzheimer’s disease: A literature review
Wesenhagen, K. E. J., Teunissen, C. E., Visser, P. J., & Tijms, B. M. (2019) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2019.1670613 · Cited by 57
Disorders of Body Weight, Sleep and Circadian Rhythm as Manifestations of Hypothalamic Dysfunction in Alzheimer’s Disease
Hiller, A. J., & Ishii, M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00471 · Cited by 59
Mind the gaps: What we don't know about cognitive impairment in essential tremor
Louis, E. D., Joyce, J. L., & Cosentino, S. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.02.038 · Cited by 58
Decreased hemodynamic response in inferior frontotemporal regions in elderly with mild cognitive impairment
Katzorke, A., Zeller, J. B. M., Müller, L. D., Lauer, M., Polak, T. T., Deckert, J., & Herrmann, M. J. (2018) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2018.02.003 · Cited by 54
Physical Activity in Preventing Alzheimer’s Disease and Cognitive Decline: A Narrative Review
Brini, S., Sohrabi, H. R., Peiffer, J. J., Karrasch, M., Hämäläinen, H., Martins, R. N., & Fairchild, T. J. (2017) · Sports Medicine · doi:10.1007/s40279-017-0787-y · Cited by 62
Advances in the development paradigm of biosample‐based biosensors for early ultrasensitive detection of alzheimer’s disease
Karki, H. P., Jang, Y., Jung, J., & Oh, J. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00814-7 · Cited by 51
Therapeutic Role of Inflammasome Inhibitors in Neurodegenerative Disorders
Lahooti, B., Chhibber, T., Bagchi, S., Varahachalam, S. P., & Jayant, R. D. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.11.004 · Cited by 50
Extracellular heat shock proteins in neurodegenerative diseases: New perspectives
Lyon, M. S., & Milligan, C. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134462 · Cited by 49
Stroke in the Time of Circadian Medicine
Mergenthaler, P., Balami, J. S., Neuhaus, A. A., Mottahedin, A., Albers, G. W., Rothwell, P. M., Saver, J. L., Young, M. E., & Buchan, A. M. (2024) · Circulation Research · doi:10.1161/circresaha.124.323508 · Cited by 43
Complex roles for reactive astrocytes in the triple transgenic mouse model of Alzheimer disease
Guillemaud, O., Ceyzériat, K., Saint-Georges, T., Cambon, K., Petit, F., Haim, L. B., Sauvage, M.-A. C.-D., Guillermier, M., Bernier, S., Hérard, A., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.02.010 · Cited by 40
A Network-Based Approach to Explore the Mechanisms of Uncaria Alkaloids in Treating Hypertension and Alleviating Alzheimer’s Disease
Wu, W., Zhang, Z., Li, F., Deng, Y., Lei, M., Long, H., Hou, J., & Wu, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051766 · Cited by 42
Modeling Alzheimer’s disease with human iPS cells: advancements, lessons, and applications
Essayan-Perez, S., Zhou, B., Nabet, A. M., Wernig, M., & Huang, Y. A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104503 · Cited by 40
Notopterygium incisum extract (NRE) rescues cognitive deficits in APP/PS1 Alzhneimer's disease mice by attenuating amyloid-beta, tau, and neuroinflammation pathology
Jiang, X., Liu, W.-W., Wu, Y., Wu, Q., Lu, H., Xu, Z., Gao, H., & Zhao, Q.-C. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112433 · Cited by 37
Dual-acting agents for improving cognition and real-world function in Alzheimer’s disease: Focus on 5-HT6 and D3 receptors as hubs
Millan, M. J., Dekeyne, A., Gobert, A., Brocco, M., la Cour, C. M., Ortuno, J., Watson, D. J., & Fone, K. C. F. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108099 · Cited by 38
Profiling the Protein Targets of Unmodified Bio‐Active Molecules with Drug Affinity Responsive Target Stability and Liquid Chromatography/Tandem Mass Spectrometry
Hwang, H., Kim, T. Y., Szász, M. A., Döme, B., Malm, J., Marko‐Varga, G., & Kwon, H. J. (2020) · PROTEOMICS · doi:10.1002/pmic.201900325 · Cited by 36
Nuclear ERK1/2 signaling potentiation enhances neuroprotection and cognition via Importinα1/KPNA2
Indrigo, M. T., Morella, I., Orellana, D. I., d’Isa, R., Papale, A., Parra, R., Gurgone, A., Lecca, D., Cavaccini, A., Tigaret, C. M., et al. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202215984 · Cited by 35
A novel therapeutic potential of cysteinyl leukotrienes and their receptors modulation in the neurological complications associated with Alzheimer's disease
Rahman, S. O., Singh, R. K., Hussain, S., Akhtar, M., & Najmi, A. K. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.10.040 · Cited by 35
Complete Evaluation of Dementia: PET and MRI Correlation and Diagnosis for the Neuroradiologist
Oldan, J. D., Jewells, V. L., Pieper, B., & Wong, T. Z. (2021) · American Journal of Neuroradiology · doi:10.3174/ajnr.a7079 · Cited by 34
In vivo and in vitro neuroprotective effects of Panax ginseng glycoproteins
Luo, H., Hu, J., Wang, Y., Chen, Y., Zhu, D., Jiang, R., & Qiu, Z. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.02.015 · Cited by 33
Recent Trends in the Management of Alzheimer’s Disease: Current Therapeutic Options and Drug Repurposing Approaches
Singh, R. K. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200128121920 · Cited by 32
Psychedelics as Novel Therapeutics in Alzheimer’s Disease: Rationale and Potential Mechanisms
Garcia‐Romeu, A., Darcy, S., Jackson, H., White, T., & Rosenberg, P. B. (2021) · Current topics in behavioral neurosciences · doi:10.1007/7854_2021_267 · Cited by 33
Biomarkers associated with the pathogenesis of Alzheimer’s disease
Wang, H., Sun, M., Li, W., Liu, X., Zhu, M., & Qin, H. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1279046 · Cited by 35
Dantrolene Ameliorates Impaired Neurogenesis and Synaptogenesis in Induced Pluripotent Stem Cell Lines Derived from Patients with Alzheimer’s Disease
Wang, Y., Liang, G., Liang, S., Mund, R., Shi, Y., & Wei, H. (2020) · Anesthesiology · doi:10.1097/aln.0000000000003224 · Cited by 30
Alzheimer's disease and synapse Loss: What can we learn from induced pluripotent stem Cells?
Rodríguez-Jiménez, F. J., Ureña‐Peralta, J. R., Jendelová, P., & Erceg, S. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.01.006 · Cited by 33
Amylin Receptor: A Potential Therapeutic Target for Alzheimer’s Disease
Fu, W., Patel, A., Kimura, R., Soudy, R., & Jhamandas, J. H. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.06.003 · Cited by 28
Alzheimer’s Disease: From Molecular Mechanisms to Promising Therapeutic Strategies
Ivanova, A. V., Kutuzova, A. D., Kuzmichev, I., & Abakumov, M. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199444 · Cited by 33
Staining and Quantification of β-Amyloid Pathology in Transgenic Mouse Models of Alzheimer’s Disease
Christensen, A., & Pike, C. J. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0592-9_19 · Cited by 27
Malignant Brain Aging: The Formidable Link Between Dysregulated Signaling Through Mechanistic Target of Rapamycin Pathways and Alzheimer’s Disease (Type 3 Diabetes)
de la Monte, S. M. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230555 · Cited by 28
The roles of long non-coding RNAs in Alzheimer's disease diagnosis, treatment, and their involvement in Alzheimer's disease immune responses
Wu, X., Xia, P., Yang, L., Lü, C., & Lu, Z. (2024) · Non-coding RNA Research · doi:10.1016/j.ncrna.2024.03.008 · Cited by 26
βAPP Processing Drives Gradual Tau Pathology in an Age-Dependent Amyloid Rat Model of Alzheimer’s Disease
Audrain, M., Souchet, B., Alves, S., Fol, R. R., Viodé, A., Haddjeri-Hopkins, A., Tada, S., Orefice, N. S., Joséphine, C., Bemelmans, A., et al. (2017) · Cerebral Cortex · doi:10.1093/cercor/bhx260 · Cited by 25
Exploring the Multi–Target Neuroprotective Chemical Space of Benzofuran Scaffolds: A New Strategy in Drug Development for Alzheimer’s Disease
Cabrera‐Pardo, J. R., Fuentealba, J., Gavilán, J., Cajas, D., Becerra, J., & Napiórkowska, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01679 · Cited by 26
Differential effects of phytotherapic preparations in the hSOD1 Drosophila melanogaster model of ALS
Rose, F. D., Marotta, R., Talani, G., Catelani, T., Solari, P., Poddighe, S., Borghero, G., Marrosu, F., Sanna, E., Kasture, S. B., et al. (2017) · Scientific Reports · doi:10.1038/srep41059 · Cited by 22
Role of the Glyoxalase System in Alzheimer’s Disease
Jiang, L., Wang, J., Wang, Z., Huang, W., Yang, Y., Cai, Z., & Li, K. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180413 · Cited by 20
MAPK signaling and a mobile scaffold complex regulate AMPA receptor transport to modulate synaptic strength
Hoerndli, F. J., Brockie, P. J., Wang, R., Mellem, J. E., Kallarackal, A. J., Doser, R. L., Pierce, D. M., Madsen, D. M., & Maricq, A. V. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110577 · Cited by 22
Newer modalities in the management of Alzheimer's dementia along with the role of aducanumab and lecanemab in the treatment of its refractory cases
Marsool, M. D. M., Prajjwal, P., Reddy, Y. B., Marsool, A. D. M., Lam, J. R., & Nandwana, V. (2023) · Disease-a-Month · doi:10.1016/j.disamonth.2023.101547 · Cited by 18
Neuronal accumulation of hyperphosphorylated tau protein predicts stable memory impairment in people living with HIV
Gonzalez, J., Wilson, A. M., Byrd, D., Cortes, E. P., Crary, J. F., & Morgello, S. (2023) · AIDS · doi:10.1097/qad.0000000000003556 · Cited by 17
Trametinib activates endogenous neurogenesis and recovers neuropathology in a model of Alzheimer’s disease
Kim, M., Kim, M. J., Lee, C., Lee, J., Kim, S. S., Hong, S., Kim, H. T., Seo, J., Yoon, K., & Han, S. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01073-2 · Cited by 17
Association between polymorphisms in the promoter region of the apolipoprotein E (APOE) gene and Alzheimers disease
Xiao, H., Gao, Y., Liu, L., & Li, Y. (2017) · EXCLI journal · doi:10.17179/excli2017-289 · Cited by 17
Infusion of hESC derived Immunity‐and‐matrix regulatory cells improves cognitive ability in early‐stage AD mice
Liu, J., Hou, Z., Wu, J., Liu, K., Li, D., Gao, T., Liu, W., An, B., Sun, Y., Mo, F., et al. (2021) · Cell Proliferation · doi:10.1111/cpr.13085 · Cited by 18
Antagonism of cysteinyl leukotrienes and their receptors as a neuroinflammatory target in Alzheimer’s disease
Singh, R. K. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04369-7 · Cited by 16
Neurodegeneration in a dish: advancing human stem-cell-based models of Alzheimer’s disease
Klimmt, J., Dannert, A., & Paquet, D. (2020) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2020.01.008 · Cited by 16
New Insights into lncRNAs in Aβ Cascade Hypothesis of Alzheimer’s Disease
Hao, Y., Xie, B., Fu, X., Xu, R., & Yang, Y. F. (2022) · Biomolecules · doi:10.3390/biom12121802 · Cited by 16
Characterization of the unique In Vitro effects of unsaturated fatty acids on the formation of amyloid β fibrils
Eto, M., Hashimoto, T., Shimizu, T., & Iwatsubo, T. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219465 · Cited by 15
Integrin β3-Mediated Cell Senescence Associates with Gut Inflammation and Intestinal Degeneration in Models of Alzheimer’s Disease
Tun, X., Wang, E. J., Gao, Z., Lundberg, K. C., Xu, R., & Hu, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065697 · Cited by 14
Gamma secretase modulators and BACE inhibitors reduce Aβ production without altering gene expression in Alzheimer’s disease iPSC-derived neurons and mice
Cusulin, C., Wells, I., Badillo, S., Duran-Pacheco, G. C., Baumann, K., & Patsch, C. (2019) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2019.103392 · Cited by 13
TM2D genes regulate Notch signaling and neuronal function in Drosophila
Salazar, J. L., Yang, S.-A., Lin, Y. Q., Li-Kroeger, D., Marcogliese, P. C., Deal, S. L., Neely, G. G., & Yamamoto, S. (2021) · PLOS Genetics · doi:10.1371/journal.pgen.1009962 · Cited by 13
Variants regulating ZBTB4 are associated with age‐at‐onset of Alzheimer's disease
Blue, E., Yu, C., Thornton, T. A., Chapman, N. H., Kernfeld, E. M., Jiang, N., Shively, K. M., Buckingham, K. J., Marvin, C. T., Bamshad, M. J., et al. (2017) · Genes Brain & Behavior · doi:10.1111/gbb.12429 · Cited by 12
Potential of molecular chaperones for treating Alzheimer’s disease
Chen, G., & Johansson, J. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01927 · Cited by 10
The Other Side of Alzheimer’s Disease: Influence of Metabolic Disorder Features for Novel Diagnostic Biomarkers
Argentati, C., Tortorella, I., Bazzucchi, M., Emiliani, C., Morena, F., & Martino, S. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030115 · Cited by 10
A multi-looping chromatin signature predicts dysregulated gene expression in neurons with familial Alzheimer’s disease mutationsPreprint
Chandrashekar, H., Simándi, Z., Choi, H., Ryu, H.-S., Waldman, A. J., Nikish, A., Muppidi, S. S., Gong, W., Paquet, D., & Phillips‐Cremins, J. E. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.27.582395 · Cited by 10
Role of NLRP3 Inflammasomes in Neurodegenerative Diseases
Demirtaş, N., Mazlumoğlu, B. Ş., & Palabıyık, Ş. S. (2023) · Eurasian Journal of Medicine · doi:10.5152/eurasianjmed.2023.23349 · Cited by 8
Restoring glucose metabolism in Alzheimer's disease by targeting integrated stress response
Sun, H., Guo, S., Jin, H., Ding, L., Chen, Y., Zhang, Y., He, K., Huang, Q., Gu, J., Chen, S., et al. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00618 · Cited by 13
Non-coding RNA biomarkers in Alzheimer’s disease
Mohammadpour, M., Saeidi, K., Ferdosi, F., Khanifar, H., Dadgostar, E., Zakizadeh, F., Abdolghaderi, S., & Khatami, S. H. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120427 · Cited by 8
Combination of Aβ Suppression and Innate Immune Activation in the Brain Significantly Attenuates Amyloid Plaque Deposition
Verbeeck, C., Carrano, A., Chakrabarty, P., Jankowsky, J. L., & Das, P. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.08.010 · Cited by 8
Potential mechanisms underlying lithium treatment for Alzheimer's disease and COVID-19.
Wei, H.-F., Anchipolovsky, S., Vera, R., Liang, G., & Chuang, D. M. (2022) · PubMed · doi:10.26355/eurrev_202203_28369 · Cited by 8
Inhibition of HDAC6 expression decreases brain injury induced by APOE4 and Aβ co‑aggregation in rats
Ding, Y., Kang, A., Tang, Q., & Zhao, Y. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10571 · Cited by 7
Could blocking the formation of amyloid channels rescue Alzheimer's phenotype?
Guix, F. X., & Dotti, C. G. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201708491 · Cited by 7
Deep Post-GWAS Analysis Identifies Potential Risk Genes and Causal Variants for Alzheimer’s Disease, Providing New Insights Into Its Disease MechanismsPreprint
Wang, Z., Zhang, Q., Lin, J.-R., Jabalameli, M. R., Mitra, J., Nguyen, N., & Zhang, Z. (2020) · doi:10.21203/rs.3.rs-31864/v1 · Cited by 7
Asymptomatic Carriers of Presenilin-1 E318G Variant Show no Cerebrospinal Fluid Biochemical Signs Suggestive of Alzheimer’s disease in a Family with Late-onset Dementia
Artuso, V., Benussi, L., Ghidoni, R., Moradi-Bachiller, S., Fusco, F., Curtolo, S., Roiter, I., Forloni, G., & Albani, D. (2018) · Current Alzheimer Research · doi:10.2174/1567205015666181031150345 · Cited by 6
Assessing the Possible Influence of Residues of Ractopamine, a Livestock Feed Additive, in Meat on Alzheimer Disease
Fan, F. S. (2021) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000515677 · Cited by 6
Zunyimycin C enhances immunity and improves cognitive impairment and its mechanism
Wang, X., Li, Z., Sun, R. X., Li, X., Guo, R., Cui, X., Liu, B., Li, W., Yang, Y., Huang, X., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1081243 · Cited by 6
Co-injection of Aβ1-40 and ApoE4 impaired spatial memory and hippocampal long-term potentiation in rats
Wu, M., He, Y., Zhang, J., Yang, J., & Qi, J. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.03.043 · Cited by 6
N6-methyladenosine RNA modification regulates microglial phagocytosis in the APP/PS1 mouse model of Alzheimer’s disease
Qu, X., Li, L., Li, Y., Chen, Y., & Chen, Y. (2025) · Genes and Immunity · doi:10.1038/s41435-025-00347-1 · Cited by 5
Harnessing the potential of long non-coding RNAs in the pathophysiology of Alzheimer's disease
Kaur, R., Pandey, S., Gupta, S. K., & Singh, J. P. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.115134 · Cited by 5
The latest perspectives of small molecules FMS kinase inhibitors
Alkubaisi, B. O., Aljobowry, R., Ali, S. M., Sultan, S., Zaraei, S., Ravi, A., Al‐Tel, T. H., & El-Gamal, M. I. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115796 · Cited by 5
Mécanismes, facteurs de risque et stratégies thérapeutiques dans la maladie d’Alzheimer
Maître, M., Klein, C., & Mensah‐Nyagan, A. G. (2017) · NPG. Neurologie, psychiatrie, gériatrie/NPG · doi:10.1016/j.npg.2016.12.006 · Cited by 5
Design, synthesis, and evaluation of benzylpiperidine-derived hydrazones as dual inhibitors of monoamine oxidases and acetylcholinesterase
Negi, N., Ayyannan, S. R., & Tripathi, R. K. P. (2024) · Medicinal Chemistry Research · doi:10.1007/s00044-024-03365-2 · Cited by 4
Phytochemicals in Life Style Associated Human Diseases
Verma, H., Gangwar, P., Yadav, A., Yadav, B., Rao, R., Kumari, S., Kaur, S., Dhiman, M., & Mantha, A. K. (2025) · Advances in Science, Technology & Innovation/Advances in science, technology & innovation · doi:10.1007/978-3-031-80973-6_19 · Cited by 3
The Therapeutic Role of Secondary Metabolites in Neurodegenerative and Inflammatory Diseases, Mechanisms, and Potential Applications
Laadraoui, J., Kabdy, H., Oufquir, S., Aitlarradia, M., Agouram, F., Aitbaba, A., Oubella, K., & El‐Mansoury, B. (2025) · IGI Global eBooks · doi:10.4018/979-8-3693-9112-9.ch005 · Cited by 3
Synthesis, crystal structure, and spectroscopic study of a novel quinoline derivative with nonlinear optical activity and esterase inhibition potential
Jamal, A., Faizi, M. S. H., & Roy, A. K. (2025) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2025.144407 · Cited by 3
PET Imaging Agents for Alzheimer’s Disease
Choi, S., Plöessl, K., Zhu, L., & Kung, H. F. (2017) · Topics in medicinal chemistry · doi:10.1007/7355_2016_18 · Cited by 2
Modulation of ERK1/MAPK3 potentiates ERK nuclear signalling, facilitates neuronal cell survival and improves memory in mouse models of neurodegenerative disordersPreprint
Indrigo, M. T., Morella, I., Orellana, D. I., d’Isa, R., Papale, A., Parra, R., Gurgone, A., Lecca, D., Cavaccini, A., Tigaret, C. M., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/496141 · Cited by 2
Nanotechnology Applications in Food and Nutrition Science
rizi, K. S., Rezayi, M., Aryan, E., Meshkat, Z., & Ghayour‐Mobarhan, M. (2022) · Wiley eBooks · doi:10.1002/9781119558026.ch8 · Cited by 2
Hurdles and Strategies in Treating Alzheimer’s Disease
Qureshi, T., Desale, S. E., Chidambaram, H., & Chinnathambi, S. (2024) · Springer eBooks · doi:10.1007/978-981-96-0259-9_6 · Cited by 1

Authors: Sala Frigerio, C., & De Strooper, B.
Affiliations: VIB Center for the Biology of Disease, Vlaams Instituut voor Biotechnologie, Leuven 3000, Belgium;,
Venue: Annual Review of Neuroscience
Publisher: Annual Reviews
Published: 2016-07-08
Volume: 39
Issue: 1
Pages: 57-79
ISSN: 0147-006X (ISSN-L)
1545-4126
DOI: 10.1146/annurev-neuro-070815-014015
OpenAlex: W2219854607
Cited by: 116
References: 163
Citations by year: 2025: 10 · 2024: 9 · 2023: 10 · 2022: 10 · 2021: 11 · 2020: 22 · 2019: 14 · 2018: 16 · 2017: 14
FWCI: 1.72
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Annual Review of Neuroscience (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Lirias (submittedVersion)
Funders: Fonds Wetenschappelijk Onderzoek
KU Leuven
Vlaamse regering
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: Alzheimer's disease, prodromal symptoms, amyloid plaques, neurofibrillary tangles, disease progression, genetic risk factors, cell culture model, animal models, drug development
MeSH terms: Alzheimer Disease, Animals, Brain, Disease Models, Animal, Humans, Amyloid beta-Peptides, tau Proteins, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Alzheimer's Disease Mechanisms and Emerging Roads to Novel Therapeutics

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks